Researchers in Prof. Liqun Luo's laboratory have developed a mouse model system for in vivo, non-invasive, spatially- and temporally-controlled labeling of individual synapses.
Inventors at Stanford developed a method to leverage mass cytometry, a type of flow cytometry utilizing mass spectrometry, for the detection of heavy metals in leukocytes from individuals exposed to heavy metals in elevated air pollution.
These dual-function nanoparticles improve selectivity of myeloid treatment via identification and reduction of tumor progression in a two-step process: initial accumulation in tumor microenvironments, followed by targeted delivery of a therapeutic payload.
Researchers at Stanford and their colleagues have developed compositions and methods for producing improved lipid nanodiscs that enable more effective studies of membrane proteins. Traditionally, scientists have studied proteins using x-ray crystallography.
Stanford researchers have patented methods to improve phagocytosis, the process by which macrophages clear protein aggregates, dying cells, and debris, to treat age-related diseases.
Researchers at Stanford and the Chan Zuckerberg Biohub have discovered cross reactive, broadly neutralizing human antibodies against all serotypes of dengue virus.
Researchers from Dr. Mark Kay's laboratory at Stanford University have merged desirable qualities of multiple natural AAV isolates by an adapted DNA family shuffling technology to create a complex library of hybrid capsids from eight different wild-type viruses.
Researchers in Prof. Mark Brongersma's laboratory have engineered a novel patterning scheme for semiconductor nanowires to increase their photon absorption in thin films for solar cells and photo-detectors.
Stanford researchers developed a wireless power transfer mechanism that will charge devices while on the move, or in use. The mechanism uses a parity-time symmetric circuit incorporating a nonlinear gain saturation element.
Researchers in the Wyss-Coray Lab are investigating a potential therapeutic antibody to treat lysosomal storage disorders and other related neurodegenerative diseases.
Researchers in Dr. Cutkosky's laboratory have developed a gripper device that allows industrial robots to handle very soft or delicate objects. Effective handling of delicate objects remains a challenging problem in manufacturing.
Anti-mouse endoglin MAb MJ7/18.
A rat IgG2A MAb recognizing mouse endoglin. In the mouse, endoglin serves as a specific endothelial cell differentiation antigen. Endoglin has been implicated as TGFb3-binding molecule.